Side-by-side comparison of AI visibility scores, market position, and capabilities
Paris CAC 40 luxury group (Euronext: KER) owning Gucci/Saint Laurent/Bottega Veneta/Balenciaga; new CEO Luca de Meo (Sep 2025) tasked with Gucci revenue recovery competing with LVMH for ultra-luxury market share.
Kering S.A. is a Paris, France-based global luxury goods group — publicly traded on Euronext Paris (EPA: KER) as a CAC 40 component — owning and operating a portfolio of iconic luxury fashion, leather goods, jewelry, and eyewear houses including Gucci, Saint Laurent, Bottega Veneta, Balenciaga, Alexander McQueen, Brioni, Boucheron, Pomellato, DoDo, Qeelin, and Kering Eyewear through approximately 47,000 employees and 1,813 directly operated stores worldwide. Founded in 1962 by François Pinault as a timber and building materials trading company, Kering (formerly Pinault-Printemps-Redoute, then PPR) transformed into a luxury group through landmark acquisitions: Gucci Group in 1999 ($3 billion, acquiring Gucci, Saint Laurent, Bottega Veneta, Balenciaga, and Alexander McQueen), rebranding from PPR to Kering in 2013 to signal the luxury focus. François-Henri Pinault (François's son) served as Chairman and CEO for nearly two decades before Luca de Meo was appointed CEO in September 2025 — with François-Henri remaining as Executive Chairman. Kering generates approximately €17-20 billion in annual revenue, with Gucci historically accounting for approximately 50% of group revenue.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.